Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Neutralizing IL-17 during re-activation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and IL-1

Figure 1

Joint swelling, (b) inflammation, and (c) bone erosion in arthritic mice before (background) and after flare-up of experimental arthritis, treated with anti-IL-17 antibodies or control antibodies. * P < 0.01, ** P < 0.005 versus control-treated group. R/L ratio, ratio between the mouse right inflamed knee joint (R) and left uninflamed knee joint (L).

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us